Atopic dermatitis: Immunobiology and treatment with immune modulators

Clinical and Experimental Immunology, Supplement

Volumn 107, Issue SUPPL. 1, 1997, Pages 25-30

  Leung, D Y M ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Allergy; Atopic dermatitis; Eczema; Skin; T lymphocytes

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; METHOXSALEN; RECOMBINANT GAMMA INTERFERON; TACROLIMUS;

ATOPIC DERMATITIS; CONFERENCE PAPER; GENE EXPRESSION; HUMAN; IMMUNOBIOLOGY; IMMUNOMODULATION; PATHOGENESIS; PRIORITY JOURNAL; PUVA; T LYMPHOCYTE; ULTRAVIOLET A RADIATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DERMATITIS, ATOPIC; HUMANS; SKIN; TH2 CELLS;

EID: 0031014937     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92:44-7.
2. Leung DYM, Rhodes AR, Geha RS et al. Atopic dermatitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freeberg IM, Austen KF, eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1993: 1543-64.
3. Jones SM, Sampson HA. The role of allergens in atopic dermatitis. Clin Rev Allergy 1993; 11:471-90.
4. May CE. Objective clinical and laboratory studies of immediate hypersensitivity reactions to foods in asthmatic children. J Allergy Clin Immunol 1976; 58:500-15.
5. Lacour M, Hauser C. The role of microorganisms in atopic dermatitis. Clin Rev Allergy 1993; 11:491-522.
6. Leung DYM, Geha RS. Clinical and immunologic aspects of the hyper IgE syndrome. In: Hematol Oncol Clin North Am, Vol. 2. Philadelphia: W.B. Saunders, Co., 1988:81-100.
7. Leung DYM, Travers JB, Norris DA. Superantigens in skin disease. J Invest Dermatol 1995; 105:37S-42S.
8. Leung DYM, Gately M, Trumble A et al. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 1995; 181:747-53.
9. Leung DYM, Harbeck R, Bina P et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993; 92: 1374-80.
10. Ezepchuk YV, Norris DA, Middleton MH, Leung DYM. Keratinocytes as target cells for staphylococcal toxins. J Invest Dermatol 1995; 104:611 (#342).
11. Mosmann TR, Cherwinski H, Bond MW et al. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secretory proteins. J Immunol 1986; 136:2348-57.
12. Vercelli D, Geha RS. Regulation of IgE synthesis: from membrane to the genes. Springer Semin Immunopathol 1993; 15:5-16.
13. Bochner BS, Klunk DA, Sterbinsky SA et al. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995; 154:799-803.
14. Chan SC, Kim JW, Henderson WR, Hanifin JM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993; 151:3345-52.
15. Ohman JD, Hanifin JM, Nickoloff BJ. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995; 154:1956-63.
16. Leung DYM. Immunopathology of atopic dermatitis. Springer Semin Immunopathol 1992; 13:427-40.
17. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994; 94:870-6.
18. Tsicopoulous A, Hamid Q, Varney V et al. Preferential messenger RNA expression of Th1-type cells (IFN-γt, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 1992; 148:2058-61.
19. Kay AM, Ying S, Varney V et al. Messenger RNA expression of cytokine gene cluster, interleukin 3 (IL-3), IL-5, and granulocyte/ macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173:775-8.
20. Bieber T, de la Salle H, Wollenberg A et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 1992; 175:1285-90.
21. 2/CD23 on normal human monocytes. J Exp Med 1988; 167:1406-16.
22. Mudde GC, Van Reijsen FC, Boland GJ et al. Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 1990; 69:335-41.
23. Engman MF, Weiss RS, Engman ME Jr. Eczema and environment. Med Clin North Am 1936; 20:651-63.
24. Leung DYM, Cotran RS, Pober JS. Expression of an endothelial leukocyte adhesion molecule (ELAM-1) in elicited late phase allergic skin reactions. J Clin Invest 1991; 87:1805-10.
25. Schleimer RP, Sterbinsky SA, Kaiser J et al. Interleukin-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J Immunol 1992; 148:1086-92.
26. Picker LJ, Butcher EC. Physiogical and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1992; 10:561-91.
27. Berg EL, Yoshin T, Rott LS et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991; 174: 1461-6.
28. Abemathy-Carver KJ, Sampson HA, Picker LJ, Leung DYM. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995; 95:913-8.
29. Babi LFS, Picker LJ, Soler MTP. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor the cutaneous lymphocyte-associated antigen (CLA). J Exp Med 1995. in press.
30. Cooper KD. New therapeutic approaches in atopic dermatitis. Clin Rev Allergy 1993; 11:543-60.
31. Boguniewicz M, Jaffe HS, Izu A et al. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990; 88:365-70.
32. Hanifin J, Schneider L, Leung D et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993; 28:189-97.
33. Sowden JM, Berth-Jones J, Ross JS et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338:137-40.
34. Michael G, Kemény Homey B, Ruzicka T. FK506 in the treatment of inflammatory skin disease: promises and perspectives. Immunol Today 1996; 17:106-8.
35. Nakagawa H, Etoh T, Ishibashi Y et al. Tacrolimus ointment for atopic dermatitis. Lancet 1994; 344:883.
36. Chan SC, Hanifin JM. Immunopharmacologic aspects of atopic dermatitis. Clin Rev Allergy 1993; 11:523-42.